Francesco Barbabella and Maria Gabriella Melchiorre: Good practice and e-health technology in multimorbidity programmes

The ICARE4EU project wants to improve the care of people who are suffering from multiple chronic conditions. It will describe, analyse, and identify innovative integrated care models for people with multimorbidity in 31 European countries, and aims to contribute to the more effective implementation of such models. During the project (which runs from 2013 to […]

Read More…

The BMJ Today: Editor’s delights

Self prescribing among doctors is legal and commonplace, but its potential problems have been recognised for many years, and regulators are increasingly taking a dim view, writes BMJ Careers editor Tom Moberly in a feature. He reviews the concerns of self prescribing as reflected in guidance from medical authorities around the world, advising doctors against […]

Read More…

Richard Lehman’s journal review—8 December 2014

NEJM 4 December 2014 Vol 371 2227 “We need to remember that these drugs also have toxic effects, they are enormously and inappropriately expensive, and they haven’t cured anyone yet. It is premature to be opening the victory champagne bottles.” Yes, this editorial refers to a new drug class for cancers—the ALK inhibitors. But it […]

Read More…

The BMJ Today: Male circumcision and medical suicides

The US Centers for Disease Control and Prevention is recommending that doctors start telling uncircumcised sexually active teenage boys they can reduce their risk of contracting HIV and other sexually transmitted disease if they have the surgery. The draft proposal also applies to adult heterosexual men and for expectant parents as they decide about newborn circumcision. […]

Read More…

Vaibhav Bagaria: Of God’s “own men”

Recently, the medical fraternity of India has been in the spotlight on various accounts. While the highest court of the country proclaimed that medical professionals were “agents of god,” and that they should not engage in striking; another high court in the country informed and “ruled” that “all of us have suffered at the hands of doctors.” […]

Read More…

Khaled E Emam: Towards standards for anonymizing clinical trials data

Although we are still at the early stages, manufacturers are starting to make individual participant data (IPD) from their clinical trials available. One of the key issues that has to be addressed is how to deal with the privacy question. If clinical trial data are anonymized, then it can be shared without having to go […]

Read More…